Wednesday, April 2, 2025 4/2/2025

Innate immune receptor driven programmed necrosis is coupled to hyper-synthesis of inflammatory lipid mediators in host defense

Award Number: R21AI180181
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Description

Innate immune receptor driven programmed necrosis is coupled to hyper-synthesis of inflammatory lipid mediators in host defense - PROJECT SUMMARY Inflammatory responses organized by innate immune cells are critical to defend against infectious insult and initiate healing responses to injury. Mechanisms that tether the strength of the inflammatory response to the magnitude of the threat are equally important to limit unnecessarily damaging aspects of the innate immune response. Inflammatory modes of programmed cell death such as necroptosis are a critical last line of cell intrinsic defense to remove infected and irreparable cells while simultaneously creating and expanding an inflammatory state in remaining healthy tissues. How inflammatory modes of death such as necroptosis create inflammation is important to understand as it not only provides insight into the roles of necroptosis in defense against specific pathogens, but also helps to identify therapeutic targets that can be pharmaceutically leveraged to inhibit out of control inflammation in disease states typified by unregulated necroptotic death. We have identified a new regulatory circuit by which the necroptotic cell death pathway is coupled to the hyperproduction and release of inflammatory lipid mediators. The active synthesis of inflammatory lipids during necroptotic death critically requires the activity of RIP kinase 3 and may impinge upon specific phospho- lipases. We hypothesize that this linkage of cell death and lipid metabolism can significantly shape inflammatory responses in vitro and in vivo. In AIM 1 we will define the mechanism by which canonical necroptotic signals govern hyper-lipid production in primary immune cells. In AIM2 we will explore the implications of this phenomena for necroptosis associated inflammation.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $194,375 )
2025	2025	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Allergy and Infectious Diseases Research	000	2	3/25/2025	NON-COMPETING CONTINUATION	$194,375
														Subtotal = $194,375

Issue Date FY: 2024 ( Subtotal = $233,250 )
2024	2024	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Allergy and Infectious Diseases Research	000	1	5/17/2024	NEW	$209,925
2024	2024	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Allergy and Infectious Diseases Research	001	1	9/11/2024	NEW	$23,325
														Subtotal = $233,250

Grand Total All Awards = $427,625

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Innate immune receptor driven programmed necrosis is coupled to hyper-synthesis of inflammatory lipid mediators in host defense

Award Number: R21AI180181

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer